Teligent, Inc. (TLGT:NASDAQ) Annual Reports & Investor Relations Material

Overview

Teligent is a company focused on the production and distribution of specialty generic prescription drugs. Their goal is to become a major player in this market and provide innovative and cost-effective solutions for patients and healthcare professionals. With a specialized approach to generics, Teligent aims to bring high-quality and affordable medications to market, meeting the needs of patients and providers alike. As a specialty pharmaceutical company, Teligent's unique business model and commitment to innovation make them one to watch in the industry.

Frequently Asked Questions

What is Teligent, Inc.'s ticker?

Teligent, Inc.'s ticker is TLGT

What exchange is Teligent, Inc. traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Teligent, Inc.'s headquarters?

They are based in Buena, New Jersey

How many employees does Teligent, Inc. have?

There are 201-500 employees working at Teligent, Inc.

What is Teligent, Inc.'s website?

It is https://www.teligent.com/

What type of sector is Teligent, Inc.?

Teligent, Inc. is in the Healthcare sector

What type of industry is Teligent, Inc.?

Teligent, Inc. is in the Drug Manufacturers - Other industry

Who are Teligent, Inc.'s peers and competitors?

The following five companies are Teligent, Inc.'s industry peers:

- Elanco Animal Health

- Heron Therapeutics Inc

- Endo International

- Neoleukin Therapeutics

- Durect Corp.